Veradigm | MDRX - Przychody Ze Sprzedaży





Obroty Zmiana Data
Alcidion AUD 25.47M 2.32M 2025-12
Ambu A/S DKK 1.57B 10M 2026-03
Amplifon EUR 606M 26.1M 2026-06
Cardinal Health USD 63.7B 2.8B 2026-06
Centene USD 53.58B 3.64B 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Cigna USD 71.7B 3.18B 2026-06
Coloplast 7.04B 83M 2025-12
Convatec Group USD 1.26B 80M 2025-12
CVS Health USD 106.1B 5.7B 2026-06
Diasorin EUR 315M 22.49M 2026-06
Elevance Health USD 49.8B 300M 2026-06
General Electric Aerospace USD 12.63B 1.03B 2026-06
Gulf Medical Proj AED 194.39M 19.38M 2026-03
Humana USD 40.89B 1.24B 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Maximus USD 1.28B 30M 2026-06
McKesson USD 105.38B 13.08B 2026-06
Med Life RON 853M 65.04M 2026-03
Molina Healthcare USD 10.87B 70M 2026-06
Omnicell USD 312.21M 2.33M 2026-06
Oriola-kd EUR 49.8M 452.2M 2026-03
Owens Minor USD 708.97M 11.71M 2025-12
Quest Diagnostics USD 3.04B 140M 2026-06
Rede D'or Sao Luiz BRL 14.91B 350M 2026-06
Siemens Healthineers EUR 5.76B 80M 2026-06
Sonova Holding CHF 1.82B 216.8M 2025-12
Supermax Corporation Bhd MYR 126.8M 60.64M 2026-03
UnitedHealth USD 112B 300M 2026-06
Veeva Systems USD 882.95M 47M 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Xerox USD 2.03B 70M 2025-12